DLL3 and neoplasm: From the four cases with several samples, three (75%) showed a concordant DLL3 expression between the samples (two DLL3-low, one DLL3-high), and the other one showed high-DLL3 expression in the primary tumor and low-DLL3 expression in the metastatic site.